Sulfonamides

Key Points

  • Sulfonamides are among the oldest broad-spectrum antimicrobials and are primarily bacteriostatic.
  • They inhibit bacterial metabolic enzymes needed for folate-related growth processes.
  • Common uses include urinary tract infection, otitis media, acute exacerbation of chronic bronchitis, and travel-associated diarrhea.
  • Allergic and delayed hypersensitivity reactions are common; discontinue at first rash and escalate promptly.
  • Encourage hydration to reduce crystalluria and renal complications.
  • For trimethoprim-sulfamethoxazole, monitor for bleeding risk with warfarin and hypoglycemia with oral antidiabetic therapy.

Mechanism of Action

Sulfonamides competitively inhibit bacterial metabolic enzymes required for cellular function and replication, producing bacteriostatic growth suppression against susceptible gram-positive and gram-negative organisms.

Clinical Use

  • Urinary tract infections.
  • Otitis media.
  • Acute exacerbations of chronic bronchitis.
  • Traveler’s diarrhea.

Prototype medication in this source: trimethoprim-sulfamethoxazole (TMP-SMX).

Nursing Considerations

  • Check for sulfonamide allergy history before first dose.
  • Monitor closely for delayed hypersensitivity reactions and stop therapy at the first sign of rash.
  • Anticipate renal dose adjustment in kidney impairment.
  • Administer oral TMP-SMX with 8 oz water and reinforce daily hydration to reduce crystalluria risk.
  • Monitor urine output and assess for cloudy urine or crystal-related urinary changes.
  • Do not administer TMP-SMX intramuscularly.
  • Use caution with cardiac antidysrhythmic therapy, oral antidiabetics (hypoglycemia risk), and anticoagulants such as warfarin (bleeding risk).
  • Monitor INR and signs of bleeding when concurrent anticoagulant therapy is present.
  • Track infection response with WBC trend, fever trend, infection-site assessment, and available culture results.

Side Effects and Adverse Effects

  • Common: nausea, vomiting, diarrhea, headache.
  • Dermatologic: photosensitivity and rash.
  • Renal: crystalluria, potential kidney stone formation, or reduced kidney function.
  • Hematologic: bruising or bleeding tendency; platelet monitoring may be needed during prolonged therapy.

Health Teaching

  • Complete the full prescribed course and avoid skipped doses.
  • If a dose is missed, take it when remembered unless it is close to the next scheduled dose.
  • Use sunscreen and protective clothing due to photosensitivity risk.
  • Report rash, sore throat, fever, mouth sores, unusual bleeding, or bruising immediately.
  • Report persistent GI symptoms or worsening infection findings promptly.

Self-Check

  1. Which early finding requires immediate discontinuation of sulfonamide therapy?
  2. Why is hydration emphasized during TMP-SMX treatment?
  3. What lab and bedside monitoring priorities apply when TMP-SMX is combined with warfarin?